"10.1371_journal.pone.0060292","plos one","2013-04-01T00:00:00Z","Lindsay B Weitzel; Amrut V Ambardekar; Andreas Brieke; Joseph C Cleveland; Natalie J Serkova; Paul E Wischmeyer; Brian D Lowes","Department of Anesthesiology, University of Colorado Anschutz Medical Campus, Aurora, Colorado, United States of America; Department of Cardiology, University of Colorado Anschutz Medical Campus, Aurora, Colorado, United States of America; Department of Surgery, University of Colorado Anschutz Medical Campus, Aurora, Colorado, United States of America; Department of Cardiology, University of Nebraska Medical Center, Omaha, Nebraska, United States of America","Conceived and designed the experiments: LW BL PW NS JC. Performed the experiments: NS. Analyzed the data: BL LW. Contributed reagents/materials/analysis tools: NS PW BL JC. Wrote the paper: LW BL AA AB.","Andreas Brieke, MD is sub-PI for LVAD studies supported by Thoratec and HeartWare. LVADs are marketed by Thoratec and HeartWare. The remaining authors have no conflicts of interest to disclose. Joe Cleveland, MD was a surgical PI for the HeartMate II destination therapy trial and the Endurance therapy trial. Paul Wischmeyer, MD has received funding from Fresenius for trials related to glutamine therapy and has patents pending for glutamines use to enhance heat shock protein expression. There are no further patents, products in development or marketed products to declare. This does not alter the authors adherence to all the PLOS ONE policies on sharing data and materials, as detailed online in the guide for authors.","2013","04","Lindsay B Weitzel","LBW",7,TRUE,5,1,2,4,TRUE,TRUE,FALSE,0,NA,FALSE
